Concepedia

Martin Sendzik

MS

18

Publications

957

Citations

15

H-Index

1998

Active since

Affiliations

Novartis (United States)(Current)

Harvard University

University of Münster

Novartis (China)

Martin Sendzik is an author at Novartis (United States) specializing in medicine, pharmacology, and natural sciences.

Top concepts

Publications per year

1998–2022

18

Publications

18

Identification of TNO155, an Allosteric SHP2 Inhibitor for the Treatment of Cancer

Matthew J. LaMarche, Michael Acker, Andreea Argintaru et al. · Journal of Medicinal Chemistry · 2020 · 207 citations · Full text

Dual Allosteric Inhibition of SHP2 Phosphatase

Michelle Fodor, Edmund V. Price, Ping Wang et al. · ACS Chemical Biology · 2018 · 127 citations · Full text

Discovery and Evaluation of Clinical Candidate IDH305, a Brain Penetrant Mutant IDH1 Inhibitor

Young Shin Cho, Julian Levell, Gang Liu et al. · ACS Medicinal Chemistry Letters · 2017 · 113 citations · Full text

6-Amino-3-methylpyrimidinones as Potent, Selective, and Orally Efficacious SHP2 Inhibitors

Patrick Sarver, Michael Acker, Jeffrey T. Bagdanoff et al. · Journal of Medicinal Chemistry · 2019 · 85 citations · Full text

, , +15

Optimization of Fused Bicyclic Allosteric SHP2 Inhibitors

Jeffrey T. Bagdanoff, Zhouliang Chen, Michael Acker et al. · Journal of Medicinal Chemistry · 2019 · 79 citations · Full text

, , +16

Rows per page

1–5 of 18